The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer

被引：0
|
作者：
Fen Wang
Feng Jin
Boran Cheng
Yue Zhang
Qing Zhou
Shubin Wang
机构：
[1] Shenzhen-Peking University-Hong Kong University of Science and Technology Medical Center,Department of Oncology, Shenzhen Key Laboratory of Gastrointestinal Cancer Translational Research, Cancer Institute, Peking University Shenzhen Hospital
[2] Southern Medical University,Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People’s Hospital, The Second School of Clinical Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Anlotinib; Non-small cell lung cancer; Real world; Tyrosine kinase inhibitor; Anti-angiogenesis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1721 / 1735
页数：14
相关论文
共 50 条
  • [1] The real-world efficacy and safety of anlotinib in advanced non-small cell lung cancer
    Wang, Fen
    Jin, Feng
    Cheng, Boran
    Zhang, Yue
    Zhou, Qing
    Wang, Shubin
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (07) : 1721 - 1735
  • [2] Efficacy and Safety of Anlotinib in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhang, Kun
    Ma, Xiya
    Gao, Hongjun
    Wang, Hong
    Qin, Haifeng
    Yang, Shaoxing
    Liu, Xiaoqing
    [J]. CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 3409 - 3417
  • [3] The Real-World Efficacy and Safety of Anlotinib Treatment for Advanced Non-Small Cell Lung Cancer
    Wang, F.
    Jin, F.
    Wang, S.
    Zhu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S673 - S673
  • [4] A Real-World Study: Efficacy and Safety of Anlotinib for Advanced Non-Small Cell Lung Cancer
    Wang, J.
    Yi, T.
    Dong, Y.
    Ran, R.
    Cao, F.
    Li, Y.
    Luo, Z.
    Xu, Y.
    Fu, Y.
    Kuang, L.
    Chen, G.
    Qu, G.
    Yin, Y.
    Li, J.
    Xu, X.
    Chen, Y.
    Song, Q.
    Chu, Q.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1071 - S1071
  • [5] Real-World Efficacy and Safety of Anlotinib with and without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Q.
    Qin, B.
    Xin, L.
    Yang, B.
    Hu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S676 - S676
  • [6] Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Qi
    Qin, Boyu
    Xin, Lingli
    Yang, Bo
    Song, Qi
    Wang, Yu
    Zhang, Sujie
    Hu, Yi
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Efficacy and Safety of Anlotinib in Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Zhong, Qiuxia
    Liu, Zhihua
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 4115 - 4128
  • [8] A real-world study update: Efficacy and safety of anlotinib for advanced non-small cell lung cancer.
    Wang, Jinlin
    Yi, Tienan
    Dong, Youhong
    Xu, Xinhua
    Cao, Fengjun
    Ran, Ruizhi
    Yin, Yifa
    Li, Yinping
    Fu, Yang
    Xu, Yanhua
    Kuang, Li
    Chen, Guiming
    Qu, Guangqiao
    Li, Jun
    Luo, Zhiguo
    Chen, Yuan
    Song, Qibin
    Chu, Qian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] Update on real-world efficacy of anlotinib in non-small cell lung cancer
    Gao, Junzhen
    Xu, Yan
    Liu, Yonggang
    Liang, Li
    Yu, Yan
    Zhao, Dahai
    Jin, Jiahui
    Wang, Mengzhao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Sun, Lei
    Zhao, Qi
    Wang, Yanning
    Wang, Yongsheng
    Zheng, Ming
    Ding, Xuansheng
    Miao, Liyun
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4165 - 4179
12345